{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:04:20Z","timestamp":1761822260993,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.rec.2021.10.012","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T17:09:52Z","timestamp":1642180192000},"page":"727-733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intracoronary eptifibatide with vasodilators to prevent no-reflow in diabetic STEMI with high thrombus burden. A randomized trial"],"prefix":"10.1016","volume":"75","author":[{"given":"Mohamed","family":"Hamza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Islam Y.","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2021.10.012_bib0145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2021.10.012_bib0150","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.CIR.101.5.570","article-title":"Recognition of the importance of embolization in atherosclerotic vascular disease","volume":"101","author":"Topol","year":"2000","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2021.10.012_bib0155","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/157340312803217148","article-title":"Treating and preventing no reflow in the cardiac catheterization laboratory","volume":"8","author":"Berg","year":"2012","journal-title":"Curr Cardiol Rev."},{"key":"10.1016\/j.rec.2021.10.012_bib0160","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0002-9149(99)80410-X","article-title":"Features and outcome of no-reflow after percutaneous coronary intervention","volume":"75","author":"Abbo","year":"1995","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2021.10.012_bib0165","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0735-1097(01)01779-X","article-title":"Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction","volume":"39","author":"Stone","year":"2002","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2021.10.012_bib0170","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(98)11086-3","article-title":"Platelet GPIIb-IIIa blockers","volume":"353","author":"Topol","year":"1999","journal-title":"Lancet."},{"key":"10.1016\/j.rec.2021.10.012_bib0175","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/jama.293.14.1759","article-title":"Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials","volume":"293","author":"De Luca","year":"2005","journal-title":"JAMA."},{"key":"10.1016\/j.rec.2021.10.012_bib0180","doi-asserted-by":"crossref","unstructured":"The EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb\/IIIa blockade. Evaluation of Platelet IIb\/IIIa inhibitor for stenting. Lancet. 1998;352:87-92.","DOI":"10.1016\/S0140-6736(98)06113-3"},{"key":"10.1016\/j.rec.2021.10.012_bib0185","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0735-1097(97)00277-5","article-title":"Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction","volume":"30","author":"Taniyama","year":"1997","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2021.10.012_bib0190","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMoa013404","article-title":"Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction","volume":"346","author":"Stone","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2021.10.012_bib0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMct063503","article-title":"Primary PCI for myocardial infarction with ST-segment elevation","volume":"356","author":"Keeley","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2021.10.012_bib0200","first-page":"294065","article-title":"Local Intracoronary Eptifibatide versus Mechanical Aspiration in Patients with Acute ST-Elevation Myocardial Infarction","volume":"2014","author":"Hamza","year":"2014","journal-title":"Int J Vasc Med."},{"key":"10.1016\/j.rec.2021.10.012_bib0205","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40119-016-0073-3","article-title":"Intracoronary Eptifibatide During Primary Percutaneous Coronary Intervention in Early Versus Late Presenters with ST Segment Elevation Myocardial Infarction: A Randomized Trial","volume":"5","author":"Elbadawi","year":"2016","journal-title":"Cardiol Ther."},{"key":"10.1016\/j.rec.2021.10.012_bib0210","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2021.10.012_bib0215","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jacc.2005.04.057","article-title":"Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial","volume":"46","author":"Burzotta","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2021.10.012_bib0220","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31.","DOI":"10.2337\/dc20-S002"},{"key":"10.1016\/j.rec.2021.10.012_bib0225","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jcin.2016.11.059","article-title":"Management of No-Reflow Phenomenon in the Catheterization Laboratory","volume":"10","author":"Rezkalla","year":"2017","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.rec.2021.10.012_bib0230","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.carrev.2012.12.006","article-title":"Intracoronary glycoprotein IIb\/IIIa inhibitor infusion via a perfusion coronary catheter to decrease thrombus burden: results from the ClearWay\u2122 Multicenter Registry","volume":"14","author":"Maluenda","year":"2013","journal-title":"Cardiovasc Revasc Med."},{"key":"10.1016\/j.rec.2021.10.012_bib0235","doi-asserted-by":"crossref","first-page":"e002258","DOI":"10.1161\/CIRCINTERVENTIONS.114.002258","article-title":"Is Aspiration Thrombectomy Beneficial in Patients Undergoing Primary Percutaneous Coronary Intervention?","volume":"8","author":"Elgendy","year":"2015","journal-title":"Meta-Analysis of Randomized Trials. Circ Cardiovasc Interv."},{"key":"10.1016\/j.rec.2021.10.012_bib0240","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/clc.22691","article-title":"Long-term outcomes with aspiration thrombectomy for patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials","volume":"40","author":"Elgendy","year":"2017","journal-title":"Clin Cardiol."},{"key":"10.1016\/j.rec.2021.10.012_bib0245","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJMoa1415098","article-title":"Randomized trial of primary PCI with or without routine manual thrombectomy","volume":"372","author":"Jolly","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2021.10.012_bib0250","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.jcin.2016.06.011","article-title":"The Risk for Stroke With Aspiration Thrombectomy: Procedure or Patient Related?: Insights From a Meta-Analysis","volume":"9","author":"Mahmoud","year":"2016","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.rec.2021.10.012_bib0255","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJMoa1415098","article-title":"Randomized trial of primary PCI with or without routine manual thrombectomy","volume":"372","author":"Jolly","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2021.10.012_bib0260","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/CIRCULATIONAHA.116.025371","volume":"135","author":"Jolly","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.rec.2021.10.012_bib0265","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/CIR.0000000000000336","volume":"133","author":"Levine","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2021.10.012_bib0270","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1001\/jama.2012.421","article-title":"Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial","volume":"307","author":"Stone","year":"2012","journal-title":"JAMA."},{"key":"10.1016\/j.rec.2021.10.012_bib0275","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1093\/eurheartj\/ehp348","article-title":"Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials","volume":"30","author":"Burzotta","year":"2009","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2021.10.012_bib0280","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/eurheartj\/ehw136","article-title":"Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial","volume":"37","author":"Nazir","year":"2016","journal-title":"Eur Heart J."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585721003431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585721003431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:00:58Z","timestamp":1761822058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585721003431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1885585721003431"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2021.10.012","relation":{},"ISSN":["1885-5857"],"issn-type":[{"type":"print","value":"1885-5857"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracoronary eptifibatide with vasodilators to prevent no-reflow in diabetic STEMI with high thrombus burden. A randomized trial","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2021.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2022.02.015","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}